Trial · NCT03347396
Results by group439
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 439
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Part A: Percentage of Participants With Response to Treatment | BIVV009 | 54.2 | 95% Confidence Interval 32.8 to 74.4 | percentage of participants | |
| Part B: Number of Participants With Treatment-emergent Adverse Events (TEAEs) and Treatment-emergent Serious Adverse Events (TESAEs) | BIVV009 6.5 g | TEAEs | 16 | Participants | |
| Part B: Number of Participants With Treatment-emergent Adverse Events (TEAEs) and Treatment-emergent Serious Adverse Events (TESAEs) | BIVV009 7.5 g | TEAEs | 6 | Participants | |
| Part B: Number of Participants With Treatment-emergent Adverse Events (TEAEs) and Treatment-emergent Serious Adverse Events (TESAEs) | BIVV009 6.5 g | TESAEs | 10 | Participants | |
| Part B: Number of Participants With Treatment-emergent Adverse Events (TEAEs) and Treatment-emergent Serious Adverse Events (TESAEs) | BIVV009 7.5 g | TESAEs | 2 | Participants | |
| Part A: Mean Change From Baseline in Bilirubin Levels at the Treatment Assessment Timepoint | BIVV009 | -38.18 | 95% Confidence Interval -42.52 to -33.84 | micromoles per Liter (mcmol/L) | |
| Part A: Mean Change From Baseline in Functional Assessment of Chronic Illness Therapy (FACIT)-Fatigue Scale Score (Quality of Life) at Treatment Assessment Timepoint | BIVV009 | 10.85 | 95% Confidence Interval 8.00 to 13.70 | score on a scale | |
| Part A: Mean Change From Baseline in Lactate Dehydrogenase (LDH) at the Treatment Assessment Timepoint | BIVV009 | -126.95 | 95% Confidence Interval -218.47 to -35.42 | units per liter | |
| Part A: Number of Blood Transfusions Per Participant | BIVV009 | 0.9 | Standard Deviation 2.75 | blood transfusions per participant | |
| Part A: Number of Blood Units Transfused Per Participant | BIVV009 | 5.8 | Standard Deviation 8.47 | blood units transfused per participant | |
| Part A: Mean Change From Baseline in Hemoglobin (Hgb) Level at the Treatment Assessment Timepoint | BIVV009 | 2.60 | 95% Confidence Interval 0.74 to 4.46 | g/dL | |
| Part B: Change From Baseline in Hemoglobin (Hgb) Level at Each Specified Time Points | BIVV009 | Week 27 | 2.76 | Standard Deviation 2.20 | g/dL |
| Part B: Change From Baseline in Hemoglobin (Hgb) Level at Each Specified Time Points | BIVV009 | Week 29 | 2.77 | Standard Deviation 2.20 | g/dL |
| Part B: Change From Baseline in Hemoglobin (Hgb) Level at Each Specified Time Points | BIVV009 | Week 31 | 2.74 | Standard Deviation 1.96 | g/dL |
| Part B: Change From Baseline in Hemoglobin (Hgb) Level at Each Specified Time Points | BIVV009 | Week 33 | 2.87 | Standard Deviation 1.97 | g/dL |
| Part B: Change From Baseline in Hemoglobin (Hgb) Level at Each Specified Time Points | BIVV009 | Week 35 | 2.82 | Standard Deviation 2.10 | g/dL |
| Part B: Change From Baseline in Hemoglobin (Hgb) Level at Each Specified Time Points | BIVV009 | Week 37 | 2.71 | Standard Deviation 2.08 | g/dL |
| Part B: Change From Baseline in Hemoglobin (Hgb) Level at Each Specified Time Points | BIVV009 | Week 39 | 2.72 | Standard Deviation 2.26 | g/dL |
| Part B: Change From Baseline in Hemoglobin (Hgb) Level at Each Specified Time Points | BIVV009 | Week 41 | 2.76 | Standard Deviation 2.24 | g/dL |
| Part B: Change From Baseline in Hemoglobin (Hgb) Level at Each Specified Time Points | BIVV009 | Week 43 | 2.73 | Standard Deviation 2.06 | g/dL |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03347396/results